Amy Ronczka
About Amy Ronczka
Amy Ronczka is the Vice President of Clinical Operations at Carisma Therapeutics, where she leads global clinical operations teams and accelerates timelines for oncology clinical trials. With a background in biology and extensive experience in clinical operations, she has held various leadership roles at Bristol-Myers Squibb prior to her current position.
Work at Carisma Therapeutics
Amy Ronczka serves as the Vice President of Clinical Operations at Carisma Therapeutics, a role she has held since 2020. In this position, she is responsible for leading global clinical operations teams in executing clinical trials. Her focus is on accelerating timelines and transforming challenging oncology clinical trials, leveraging her extensive expertise in operational strategies for large-scale oncology programs.
Previous Experience at Bristol-Myers Squibb
Prior to her current role, Amy Ronczka worked at Bristol-Myers Squibb for a total of seven years in various capacities. She served as a Clinical Scientist/Site Manager/Data Manager from 2001 to 2008, followed by her position as Senior Clinical Protocol Manager from 2008 to 2015. Additionally, she was the Clinical Operations Lead for Immuno-Oncology from 2015 to 2018. In these roles, she developed skills in strategic planning and building high-performing teams.
Education and Expertise
Amy Ronczka studied Biology at Saint Joseph College from 2005 to 2011, earning a degree in the field. Prior to that, she attended Southern Connecticut State University, where she completed a Bachelor of Science in Biology from 2001 to 2003. Her educational background, combined with her extensive experience in clinical operations, has equipped her with the knowledge and skills necessary for her leadership roles in oncology clinical trials.
Leadership and Team Collaboration
Amy Ronczka is recognized for her ability to create a visionary environment characterized by trust, collaboration, and innovation. She is skilled in building high-performing teams and collaborating with senior stakeholders. Her leadership style emphasizes strategic planning and execution of complex pivotal clinical trials, contributing to her reputation as a proven leader in the field of clinical operations.